FISIOLOGÍA Y FARMACOLOGÍA
Departamento
Institut d'Investigació Biomédica de Bellvitge
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institut d'Investigació Biomédica de Bellvitge (12)
2024
-
Experimental Model of Biliary Tract Cancers: Subcutaneous Xenograft of Human Cell Lines in Immunodeficient Nude Mice
Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 87-98
2023
-
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480
-
Intrinsic cancer cell phosphoinositide 3-kinase δ regulates fibrosis and vascular development in cholangiocarcinoma
Liver International, Vol. 43, Núm. 12, pp. 2776-2793
-
TGFβ-induced circLTBP2 predicts a poor prognosis in intrahepatic cholangiocarcinoma and mediates gemcitabine resistance by sponging miR-338-3p
JHEP Reports, Vol. 5, Núm. 12
2022
-
Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency–associated hypertransaminasemia
Hepatology, Vol. 76, Núm. 5, pp. 1259-1274
-
Genetic alterations shaping tumor response to anti-EGFR therapies
Drug Resistance Updates, Vol. 64
2021
-
Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity
Cell Death and Disease, Vol. 12, Núm. 6
-
Cholangiopathy aggravation is caused by VDR ablation and alleviated by VDR-independent vitamin D signaling in ABCB4 knockout mice
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1867, Núm. 4
-
STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway
Journal of Hepatology, Vol. 74, Núm. 6, pp. 1429-1441
-
The tgf-β pathway: A pharmacological target in hepatocellular carcinoma?
Cancers, Vol. 13, Núm. 13
-
Zinc Finger E-Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor–Stroma Paracrine Signaling
Hepatology, Vol. 74, Núm. 6, pp. 3194-3212